MC2 Therapeutics
Topical dermatology products, prescription and DermoCosmetic, for psoriasis and itchy, dry or sensitive skin
Highlights
- New on EvolcAdded 2026-10-29
About MC2 Therapeutics
MC2 Therapeutics develops topical dermatology products based on its proprietary PAD technology formulation platform. Its first commercial prescription product, Wynzora Cream, for plaque psoriasis, launched in the United States in 2021.
Wynzora Cream is partnered with pharmaceutical companies specialising in dermatology and is launched in Europe, the US, Australia and Canada. The company also develops DermoCosmetic products, including cosmetics and medical devices, for people with itchy, dry and sensitive skin. Its DermoCosmetic portfolio includes Chronic Itch, Intimate Itch and Dry Skin. The company works selectively with partners that have a medical orientation, established market access and a commitment to dermatology.
MC2 Therapeutics is headquartered in Guildford, United Kingdom, where its formulation laboratory is located, and also has an office in Hørsholm, Denmark. The company was founded in 2005 and is privately held. It accepts unsolicited job applications.
Product: PAD technology-based topical products: Wynzora Cream (prescription, plaque psoriasis) and DermoCosmetics (Chronic Itch, Intimate Itch, Dry Skin).
Jobs at MC2 Therapeutics
More biotech & pharma companies
Mdbiologics
UK healthcare company with separate websites for healthcare professionals and members of the publicYoung companyNew on EvolcMedherant
Clinical-stage pharma developing the TEPI Patch transdermal platform, starting with a testosterone patch for postmenopausal womenNew on EvolcMeiragtx
Develops genetic medicines and gene-regulation technologies for patients with rare and common diseasesNew on EvolcMestag Therapeutics
Immunology company developing first-in-class antibodies for cancer and inflammatory diseases based on fibroblast biologyNew on EvolcMetrion Biosciences
Preclinical CRO running ion channel, cardiac safety and neuroscience screening for pharma and biotech drug discoveryNew on EvolcMialgae
Fish-free algae DHA omega-3 ingredient for pet food and aquafeed makers, grown on Scottish whisky by-productsNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Apache
- Google Analytics 4
- Google Universal Analytics
- WordPress
- jQuery
